StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
INMInMed Pharmaceuticals Inc.
stockpulse.co.kr
Nasdaq
$1.39▼ 0.42%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $4.6MShares out 3.3M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

17
  • 4d agoAfter-hours26.10.21 06:31
    4Ownership#●●●

    InMed Pharmaceuticals Inc.

    Daniel Schneeberger and ADAR1 Capital Management, LLC, as insiders and major shareholders of InMed Pharmaceuticals, filed a Form 4 report regarding changes in their beneficial ownership of securities as of October 16, 2026. This filing details the specific adjustments to their shareholdings and equity stakes in the company.…more

    $1.39-0.42%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.15After-hours26.10.16 05:39
    4Ownership

    InMed Pharmaceuticals Inc.

    Daniel Schneeberger and ADAR1 Capital Management, both insiders and major shareholders of InMed Pharmaceuticals, reported changes in their beneficial ownership as of October 13, 2026. This Form 4 filing confirms the specific adjustments to their shareholdings in the company.…more

    $1.39-0.42%vs prev close
    View filingShare
  • 10.8After-hours26.10.09 07:27
    4Ownership

    InMed Pharmaceuticals Inc.

    Daniel Schneeberger and ADAR1 Capital Management, LLC, as insiders and major shareholders of InMed Pharmaceuticals Inc., reported changes in their beneficial ownership of securities as of October 6, 2026. This Form 4 filing details the specific shifts in their equity holdings.…more

    $1.39-0.42%vs prev close
    View filingShare

16 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.